Examples of using In all subsets in English and their translations into Swedish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
The European Medicines Agency has waived the obligation to submit the results of studies with Tarceva in all subsets of the paediatric population in Non Small Cell Lung Cancer
The European Medicines Agency has waived the obligation to submit the results of the studies with SUTENT in all subsets of the paediatric population for treatment of gastroenteropancreatic neuroendocrine tumours(excluding neuroblastoma,
The European Medicines Agency has waived the obligation to submit the results of studies with RoActemra in all subsets of the paediatric population in rheumatoid arthritis
The European Medicines Agency has waived the obligation to submit the results of studies with Docetaxel Winthrop in all subsets of the paediatric population in breast cancer,
The European Medicines Agency has waived the obligation to submit the results of studies with SUTENT in all subsets of the paediatric population for treatment of kidney
The European Medicines Agency has waived the obligation to submit the results of the studies with Lumark in all subsets of the paediatric population on grounds that the specific medicinal product is likely to be ineffective
The European Medicines Agency has waived the obligation to submit the results of studies with Abilify Maintena in all subsets of the paediatric population in schizophrenia see section 4.2.
The European Medicines Agency has waived the obligation to submit the results of studies with pemetrexed in all subsets of the paediatric population in the granted indications see section 4.2.
The European Medicines Agency has waived the obligation to submit the results of studies with Ofev in all subsets of the paediatric population in IPF see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with Votubia in all subsets of the paediatric population in angiomyolipoma see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with ANORO in all subsets of the paediatric population in COPD see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with LAVENTAIR in all subsets of the paediatric population in COPD see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with OSSEOR in all subsets of the paediatric population in osteoporosis see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with NUEDEXTA in all subsets of the paediatric population in PBA see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with ospemifene in all subsets of the paediatric population in VVA see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with Teysuno in all subsets of the paediatric population in gastric adenocarcinoma see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with Bretaris Genuair in all subsets of the paediatric population in COPD see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with enzalutamide in all subsets of the paediatric population in prostate carcinoma see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with Brimica Genuair in all subsets of the paediatric population in COPD see section 4.2 for information on paediatric use.
The European Medicines Agency has waived the obligation to submit the results of studies with Cholib in all subsets of the paediatric population in combined dyslipidaemia see section 4.2 for information on paediatric use.